Understanding Symptom Relief in Cancer Trials
Author Information
Author(s): Stephens R J, Hopwood P, Girling D J
Primary Institution: MRC Cancer Trials Office
Hypothesis
What is the best way to define and analyze symptom palliation in cancer clinical trials?
Conclusion
The study found that the four-drug chemotherapy regimen provided a significant benefit in symptom palliation compared to the two-drug regimen.
Supporting Evidence
- 90% of patients with moderate or severe cough reported improvement.
- 53% of patients with mild cough reported improvement.
- The four-drug regimen showed a significant benefit in symptom palliation.
Takeaway
This study looked at how well different cancer treatments help relieve symptoms like cough, and found that more intensive treatment worked better for patients with worse symptoms.
Methodology
The study analyzed cough relief in a large multicentre randomized clinical trial comparing two chemotherapy regimens.
Limitations
The lack of a standard definition for symptom palliation complicates the analysis and comparison of trial results.
Participant Demographics
Patients with varying severity of cough, including moderate, severe, and mild.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website